Literature DB >> 24365319

Neurologic manifestations of achondroplasia.

Jacqueline T Hecht1, John B Bodensteiner2, Ian J Butler3.   

Abstract

Achondroplasia is the best described and most common form of the congenital short-limbed dwarfing conditions. Achondroplasia is apparent at birth and has a birth prevalence of 1 in 20000-30000 live-born infants. Achondroplasia is inherited as an autosomal dominant condition, although 80% of cases occur sporadically as new events in their families. Achondroplasia is caused, in virtually all of the cases, by a G380R mutation in fibroblast growth factor receptor 3 (FGFR3). Patients with achondroplasia should be evaluated by a multidisciplinary team of clinicians including geneticists, neurologists, and orthopedists, since there are numerous bony and neurological complications. The most severe complication results from craniocervical stenosis and medullary and upper spinal cord compression, which can have devastating and even lethal sequelae during early childhood. In subsequent decades, including adolescence, spinal cord and nerve compression are more prominent. The neurological complications of achondroplasia have been recognized in adults for more than a century and are attributed to bony defects, connective tissue structures, or both. Similar neurological complications are now appreciated in infants, young children, and teenagers with achondroplasia. Defective connective tissue elements in achondroplasia frequently lead to ligamentous laxity, which can aggravate the complications associated with bony stenosis. Bony abnormalities are known to cause neurological morbidity and lead to a shortened lifespan. Neurological complications associated with achondroplasia are reviewed, including recommendations for the evaluation and management of these clinical problems.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Achondroplasia; all ages affected; dominant; endochondral bone; fibroblast growth factor receptor 3; ligamentous laxity; multidisciplinary approach

Mesh:

Year:  2014        PMID: 24365319     DOI: 10.1016/B978-0-7020-4086-3.00036-9

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  5 in total

1.  Whole-exome sequencing and whole genome re-sequencing for prenatal diagnosis of achondroplasia.

Authors:  Rong Zhao; Yan Ruan; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Current knowledge of medical complications in adults with achondroplasia: A scoping review.

Authors:  Svein O Fredwall; Grethe Maanum; Heidi Johansen; Hildegun Snekkevik; Ravi Savarirayan; Ingeborg B Lidal
Journal:  Clin Genet       Date:  2019-04-22       Impact factor: 4.438

3.  Longitudinal Imaging of the Skull Base Synchondroses Demonstrate Prevention of a Premature Ossification After Recifercept Treatment in Mouse Model of Achondroplasia.

Authors:  Guylene Rignol; Stephanie Garcia; Florence Authier; Kaamula Smith; Lionel Tosello; Raphael Marsault; Pierre Dellugat; Diogo Goncalves; Marlene Brouillard; Jeffrey Stavenhagen; Luca Santarelli; Christian Czech; Elvire Gouze
Journal:  JBMR Plus       Date:  2021-11-09

4.  Gait in children with achondroplasia - a cross-sectional study on joint kinematics and kinetics.

Authors:  Eva W Broström; Lotte Antonissen; Johan von Heideken; Anna-Clara Esbjörnsson; Lars Hagenäs; Josefine E Naili
Journal:  BMC Musculoskelet Disord       Date:  2022-04-28       Impact factor: 2.562

5.  FGFR3 gene mutation plus GRB10 gene duplication in a patient with achondroplasia plus growth delay with prenatal onset.

Authors:  Haiming Yuan; Linhuan Huang; Xizi Hu; Qian Li; Xiaofang Sun; Yingjun Xie; Shu Kong; Xiaoman Wang
Journal:  Orphanet J Rare Dis       Date:  2016-07-02       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.